Search

everythinglearnresearchcommunity

for

Search:↓

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

JAK inhibitors show promise for treating various skin diseases.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Low vitamin D levels are linked to different types of hair loss.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Histone modification is key in treating chronic inflammatory skin diseases.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.